Single‐agent gemcitabine in patients with advanced, pre‐treated angiosarcoma: A multicenter, retrospective study

Gemcitabine has shown clinical activity against angiosarcoma in small series, alone, or combined with taxanes. We aimed to evaluate its activity as a single‐agent in a larger series of patients with advanced angiosarcoma. We retrospectively reviewed the electronic medical records of consecutive adul...

Descripción completa

Detalles Bibliográficos
Autores principales: Watson, Sarah, Verret, Benjamin, Ropert, Stanislas, Adam, Julien, Bahleda, Rastislav, Briand, Sylvain, Cavalcanti, Andrea, Chamseddine, Ali N., Court, Charles, Fadel, Elie, Faron, Matthieu, Haddag‐Miliani, Leila, Henon, Clémence, Pechoux, Cécile Le, Levy, Antonin, Mercier, Olaf, Ngo, Carine, Honoré, Charles, Cesne, Axel Le, Mir, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
BRIEF COMMUNICATION
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939156/
https://www.ncbi.nlm.nih.gov/pubmed/35971325
http://dx.doi.org/10.1002/cam4.5147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939156/
https://www.ncbi.nlm.nih.gov/pubmed/35971325
http://dx.doi.org/10.1002/cam4.5147

Ejemplares similares